Key points are not available for this paper at this time.
Ovarian cancer is an aggressive malignancy and the leading cause of death among gynecologic cancers. Researchers have evaluated prophylactic medications that potentially avert the manifestation of ovarian cancer, but currently, there are no reliable screening measures for this disease. Nevertheless, the largest study involving aspirin use and ovarian cancer reported a substantive risk reduction from enduring aspirin use. Since there are countervailing data to impugn the potential benefits of aspirin use in staving off ovarian cancer, further research should scrutinize the use of this medication as a prophylactic intervention, especially in women who are at higher risk for developing the disease.
Building similarity graph...
Analyzing shared references across papers
Loading...
John P. Micha
National Foundation for Cancer Research
Mark A. Rettenmaier
National Foundation for Cancer Research
Randy Bohart
University of California, Irvine
Cancer Investigation
Cancer Research Foundation
Building similarity graph...
Analyzing shared references across papers
Loading...
Micha et al. (Fri,) studied this question.
synapsesocial.com/papers/68e614a6b6db6435875a6fb0 — DOI: https://doi.org/10.1080/07357907.2024.2375573